150 Executive Park Blvd
2 articles with Cytovale
Cytovale Announces $15 Million in Financing for Technology Enabling Early Sepsis Detection in the Emergency Department
Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, today announced $15 million in financing to advance its technology enabling early detection of sepsis in the emergency department.
Although bioterrorism doesn’t get the kind of attention more traditional bombings and shootings receive, the biotech industry and the federal government are paying attention and actively funding and developing countermeasures to potential bioterror, military and public health emergencies.